Evolving Treatment Patterns and Outcomes of Neovascular Age-Related Macular Degeneration Over a Decade.

ABSTRACT:

Purpose

Management of neovascular age-related macular degeneration (nAMD) has evolved over the last decade with several treatment regimens and medications. This study describes the treatment patterns and visual outcomes over 10 years in a large cohort of patients.

Design

Retrospective analysis of electronic health records from 27 National Health Service secondary care healthcare providers in the UK.

Participants

Treatment-naïve patients receiving at least 3 intravitreal anti-vascular endothelial growth factor (VEGF) injections for nAMD in their first 6 months of follow-up were included. Patients with missing data for age or gender and those aged less than 55 years were excluded.

Methods

Eyes with at least 3 years of follow-up were grouped by years of treatment

SUBMITTER: Schwartz R 

PROVIDER: S-EPMC9165682 | biostudies-literature | 2021 Aug

REPOSITORIES: biostudies-literature